Search Results - "Pasko, DA"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review by Long, MT, Wagner, D, Maslach-Hubbard, A, Pasko, DA, Baldridge, P, Annich, GM

    Published in Perfusion (01-03-2014)
    “…Background: Medically refractory hemorrhage in patients on ECMO (extracorporeal membrane oxygenation) support can have catastrophic complications…”
    Get full text
    Journal Article
  2. 2

    Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension by Flynn, J T, Pasko, D A

    Published in Pediatric nephrology (Berlin, West) (01-12-2000)
    “…The calcium channel blockers (CCBs) are a diverse group of antihypertensive medications with variable pharmacokinetics and clinical effects. Although CCBs have…”
    Get full text
    Journal Article
  3. 3

    Higher Renal Replacement Therapy Dose Delivery Influences on Drug Therapy by Mueller, Bruce A., Pasko, Deborah A., Sowinski, Kevin M.

    Published in Artificial organs (01-09-2003)
    “…: Higher doses of renal replacement therapy have profound effects on pharmacotherapy, yet little research has been conducted in this area. High‐volume renal…”
    Get full text
    Journal Article
  4. 4

    Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytes by PASKO, Deborah A, MOTTES, Theresa A, MUELLER, Bruce A

    Published in Pediatric nephrology (Berlin, West) (01-11-2003)
    “…In critically ill children weighing <10 kg, it is necessary to use blood as a priming solution for the extracorporeal continuous renal replacement therapy…”
    Get full text
    Journal Article
  5. 5

    Linezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case Report by Kraft, Michael D., Pasko, Deborah A., DePestel, Daryl D., Ellis, Jessica J., Peloquin, Charles A., Mueller, Bruce A.

    Published in Pharmacotherapy (01-08-2003)
    “…Objective. To determine the linezolid clearance and serum concentrations in a critically ill man receiving continuous venovenous hemodiafiltration (CVVHDF)…”
    Get full text
    Journal Article
  6. 6